{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-030804","form_type":"8-K","ticker":"AQST","cik":"0001398733","company_name":"Aquestive Therapeutics, Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.164574+00:00","generated_at":"2026-05-19T12:50:01.272425+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aquestive shareholders elect two Class I directors, approve say-on-pay, ratify KPMG at 2025 annual meeting","bullets":["Daniel Barber and Timothy E. Morris elected as Class I directors with 36,060,882 and 35,562,599 votes for, respectively.","Non-binding advisory vote on executive compensation approved: 32,454,278 for, 6,694,084 against, 459,188 abstain.","Ratification of KPMG as independent auditor for FY 2025 passed: 66,530,646 for, 1,166,766 against.","Broker non-votes of 29,848,112 on director elections and say-on-pay proposal.","Annual Meeting held June 11, 2025; results reported under Item 5.07."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-030804","json":"https://secwatch.observer/filing/0001628280-25-030804.json","markdown":"https://secwatch.observer/filing/0001628280-25-030804.md","text":"https://secwatch.observer/filing/0001628280-25-030804.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/0001628280-25-030804-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/aqst-20250611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T12:50:01.272425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}